News in brief

Dr. Reddy’s stock shares rises amid recent US FDA citations

By Maggie Lynch contact

- Last updated on GMT

(Getty: Image/xijian)
(Getty: Image/xijian)

Related tags: Stock exchange, Stock market, Fda, Form 483, India

Dr. Reddy’s Laboratories site in Visakhapatnam, India, was issued a Form 483 last month, yet shares rose after a more recent audit where zero observations were noted.

The company’s shares rose 3%​ in early trading on November 19, after an audit of the company’s site by the US Food and Drug Administration (FDA) in Andhra Pradesh, India, saw zero observations.

In a Bombay Stock Exchange filing, Dr. Reddy’s stated that the audit of its Formulations Srikakulum Plant Unit II received zero observations. The filing occurred during post-market hours on Friday, the following Monday shares jumped.

Between October 22 and October 30, 2018, however, Dr. Reddy’s site in Visakhapatnam, India, was observed by the FDA and it noted ten observations that led to the issuing of a Form 483 for its site. The observations generally regarded the Quality Unit and proper implementations to maintain sterile products.

The FDA states on its website that a Form 483​ is distributed at the conclusion of an inspection when observations regarding conditions that may constitute violations to the Food Drug and Cosmetic Act are seen.

The company’s Duvvada​ site, which primarily manufactures generic chemotherapy treatments, was issued a Form 483. A site in Bollaram​ and another in Jinneram Mandal​ were also recently given observations following audits.

Related news

Show more

Related products

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers